Abstract:Background: Computer-aided drug design has a long history of being applied to discover new molecules to treat various cancers, but it has always been focused on single targets. The development of systems biology has let scientists reveal more hidden mechanisms of cancers, but attempts to apply systems biology to cancer therapies remain at preliminary stages. Our lab has successfully developed various systems biology models for several cancers. Based on these achievements, we present the first attempt to combine multiple-target therapy with systems biology. Methods: In our previous study, we identified 28 significant proteins--i.e., common core network markers--of four types of cancers as house-keeping proteins of these cancers. In this study, we ranked these proteins by summing their carcinogenesis relevance values (CRVs) across the four cancers, and then performed docking and pharmacophore modeling to do virtual screening on the NCI database for anti-cancer drugs. We also performed pathway analysis on these proteins using Panther and MetaCore to reveal more mechanisms of these cancer house-keeping proteins. Results: We designed several approaches to discover targets for multiple-target cocktail therapies. In the first one, we identified the top 20 drugs for each of the 28 cancer house-keeping proteins, and analyzed the docking pose to further understand the interaction mechanisms of these drugs. After screening for duplicates, we found that 13 of these drugs could target 11 proteins simultaneously. In the second approach, we chose the top 5 proteins with the highest summed CRVs and used them as the drug targets. We built a pharmacophore and applied it to do virtual screening against the Life-Chemical library for anti-cancer drugs. Based on these results, wet-lab bio-scientists could freely investigate combinations of these drugs for multiple-target therapy for cancers, in contrast to the traditional single target therapy. Conclusions: Combination of systems biology with computer-aided drug design could help us develop novel drug cocktails with multiple targets. We believe this will enhance the efficiency of therapeutic practice and lead to new directions for cancer therapy.

Computer Aided Multi-target Drug Design, Multi-target Virtual Screening

In-Silico Approaches to Multi-target Drug Discovery

Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Computational Multitarget Drug Design.

Advancement of Multi-Target Drug Discoveries and Promising Applications in the Field of Alzheimer's Disease.

Application Advances on Novel Techniques in Multi-target Drugs Discovery

Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods

Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

Computer-Aided Drug Target Search

How to design multi-target drugs: Target search options in cellular networks

Recent Advances in the Rational Drug Design Based on Multi-target Ligands.

Recent Advances In The Rational Drug Design Based On Multi-Target Ligands

Research on targeted drug design based on computer technology

Improved genome-scale multi-target virtual screening via a novel collaborative filtering approach to cold-start problem

[Multi-Target Therapeutics and New Drug Discovery].

Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery

System-level multi-target drug discovery from natural products with applications to cardiovascular diseases

Targeted Molecular Diversity in Drug Discovery: Integration of Structure-Based Design and Combinatorial Chemistry

Rational Design of Multi-Target-Directed Ligands: Strategies and Emerging Paradigms.

Recent advances in multitarget-directed ligands via in silico drug discovery